You have 9 free searches left this month | for more free features.

Tenapanor

Showing 1 - 25 of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

IBS, IBS - Irritable Bowel Syndrome Trial (Tenapanor)

Not yet recruiting
  • IBS
  • IBS - Irritable Bowel Syndrome
  • Tenapanor
  • (no location specified)
Aug 10, 2023

Irritable Bowel Syndrome With Constipation (IBS-C) Trial in Foley (Tenapanor)

Enrolling by invitation
  • Irritable Bowel Syndrome With Constipation (IBS-C)
  • Tenapanor
  • Foley, Alabama
    G & L Research, LLC
Jun 13, 2023

Irritable Bowel Syndrome With Constipation (IBS-C) Trial in Foley (Tenapanor 50 MG, Tenapanor 25 mg bid, Placebo)

Recruiting
  • Irritable Bowel Syndrome With Constipation (IBS-C)
  • Tenapanor 50 MG
  • +2 more
  • Foley, Alabama
    G & L Research, LLC
Nov 30, 2022

Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia Trial in Lauderdale Lakes (Tenapanor)

Completed
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Hyperphosphatemia
  • Tenapanor
  • Lauderdale Lakes, Florida
    South Florida Research Institute
Sep 28, 2022

Hyperphosphatemia, End Stage Renal Disease Trial in Houston (Tenapanor, Sevelamer Carbonate)

Completed
  • Hyperphosphatemia
  • End Stage Renal Disease
  • Tenapanor
  • Sevelamer Carbonate
  • Houston, California
    Ardelyx Site #509
Jan 5, 2022

Constipation Predominant Irritable Bowel Syndrome Trial in Miami (Tenapanor)

Completed
  • Constipation Predominant Irritable Bowel Syndrome
  • Tenapanor
  • Miami, Florida
    Ardelyx Clinical Site
Aug 25, 2020

Hyperphosphatemia Trial in Bronx, Winston-Salem (Tenapanor, Placebo, Sevelamer Carbonate)

Completed
  • Hyperphosphatemia
  • Tenapanor
  • +2 more
  • Bronx, New York
  • +1 more
Aug 18, 2020

End Stage Renal Disease, Chronic Kidney Disease Stage 5, ESRD Trial in Tempe, Denver, Minneapolis (AZD1722 (in-patient), Placebo

Completed
  • End Stage Renal Disease
  • +2 more
  • AZD1722 (in-patient)
  • +3 more
  • Tempe, Arizona
  • +2 more
Aug 6, 2020

Hyperphosphatemia Trial in United States (Tenapanor, Placebo)

Completed
  • Hyperphosphatemia
  • Tenapanor
  • Placebo
  • Huntsville, Alabama
  • +31 more
Aug 6, 2020

Hyperphosphatemia Trial in United States (Tenapanor, Placebo, Phosphate Binder Agents)

Completed
  • Hyperphosphatemia
  • Tenapanor
  • +2 more
  • Huntsville, Alabama
  • +47 more
Aug 31, 2020

Hyperphosphatemia Trial in Niigata (KHK7791)

Completed
  • Hyperphosphatemia
  • Niigata, Japan
    Study Site 1
Jan 14, 2020

Constipation Predominant Irritable Bowel Syndrome Trial in United States (AZD1722, Placebo)

Completed
  • Constipation Predominant Irritable Bowel Syndrome
  • Boulder, Colorado
  • +3 more
Mar 31, 2020

Constipation Predominant Irritable Bowel Syndrome Trial in United States (Tenapanor, Placebo)

Completed
  • Constipation Predominant Irritable Bowel Syndrome
  • Tenapanor
  • Placebo
  • Dothan, Alabama
  • +116 more
Apr 10, 2020

Constipation Predominant Irritable Bowel Syndrome Trial in United States (Tenapanor, Placebo)

Completed
  • Constipation Predominant Irritable Bowel Syndrome
  • Tenapanor
  • Placebo
  • Birmingham, Alabama
  • +110 more
Apr 10, 2020

Hyperphosphatemia Trial in Suita (KHK7791)

Completed
  • Hyperphosphatemia
  • Suita, Osaka, Japan
    Inoue Hospital
Jan 7, 2022

Hyperphosphatemia Trial in Suita (KHK7791, Placebo)

Completed
  • Hyperphosphatemia
  • Suita, Osaka, Japan
    Inoue Hospital
Oct 26, 2021

Hyperphosphatemia Trial in Tsukuba (KHK7791, Placebo)

Completed
  • Hyperphosphatemia
  • Tsukuba, Ibaraki, Japan
    Kikuchi medical clinic
Sep 7, 2021

Hyperphosphatemia Trial in Kanoya (KHK7791)

Active, not recruiting
  • Hyperphosphatemia
  • Kanoya, Kagoshima, Japan
    Medical Corporation Seijinkai Ikeda Hospital
Sep 7, 2021

Hyperphosphatemia Trial in Chiba (KHK7791, Placebp)

Completed
  • Hyperphosphatemia
  • Chiba, Japan
    Study Site 1
Jan 14, 2020

Hyperphosphatemia Trial in Nagoya (KHK7791, Placebo)

Completed
  • Hyperphosphatemia
  • Nagoya, Japan
    Study Site 1
Jan 14, 2020

Chronic Kidney Disease, Type 2 Diabetes Trial in Denver (AZD1722, Placebo)

Completed
  • Chronic Kidney Disease
  • Type 2 Diabetes Mellitus
  • Denver, Colorado
    Creekside Endocrine Associates PC
May 9, 2020

Constipation Predominant Irritable Bowel Syndrome Trial in United States (RDX5791)

Completed
  • Constipation Predominant Irritable Bowel Syndrome
  • San Diego, California
  • +15 more
Sep 25, 2019

Healthy Trial (RDX5791, Placebo)

Completed
  • Healthy
  • (no location specified)
Jun 29, 2016

Healthy Trial (RDX5791, Placebo)

Completed
  • Healthy
  • (no location specified)
Jun 7, 2016

Healthy Trial in San Antonio (AZD1722, Renvela)

Completed
  • Healthy
  • San Antonio, Texas
    Healthcare Discoveries, LLC
Jan 26, 2015